Loading...
Repurposing Interleukin-6 Inhibitors to Combat COVID-19
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated with the development of acute respiratory dis...
Saved in:
| Published in: | J Immunother Precis Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Innovative Healthcare Institute
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221576/ https://ncbi.nlm.nih.gov/pubmed/34169296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.36401/JIPO-20-11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|